The effect of in vivo administration of recombinant methionyl human stem cell factor on the number of human marrow hematopoietic stem cells.
Tong
J
J
Hematology/Oncology Section, Indiana University School of Medicine, Indianapolis 46202.
Gordon
M S
MS
Srour
E F
EF
Cooper
R J
RJ
Orazi
A
A
McNiece
I
I
Hoffman
R
R
D000943:Antigens, Differentiation / Q000378:metabolism; D001853:Bone Marrow / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D016026:Bone Marrow Transplantation; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D002452:Cell Count; D003114:Colony-Forming Units Assay; D005260:Female; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006412:Hematopoietic Stem Cells / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use; D019089:Stem Cell Factor
D000943:Antigens, Differentiation; D016298:Hematopoietic Cell Growth Factors; D011994:Recombinant Proteins; D019089:Stem Cell Factor